Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity

W W. Timothy Garvey (Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham) M Matthias Blüher C Cynthia Karenina Osorto Contreras (Novo Nordisk, Søborg, Denmark) M Melanie J. Davies E Eva Winning Lehmann (Novo Nordisk, Søborg, Denmark) K Kirsi H. Pietilainen (Healthy Weight Hub, Helsinki University Central Hospital) D Domenica Rubino (Washington Center for Weight Management and Research, Arlington, VA) P Paolo Sbraccia (Department of Systems Medicine, University of Rome Tor Vergata, Internal Medicine Unit and Obesity Center, University Hospital Policlinico Tor Vergata, Rome) T Thomas Wadden (Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia) N Niels Zeuthen (Novo Nordisk, Søborg, Denmark) J John P.H. Wilding (Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom)

Article Details

Volume / Issue Vol. 393, Issue 7
Published August 14, 2025
Pages 635-647
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (11)

W

W. Timothy Garvey

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham

M

Matthias Blüher

C

Cynthia Karenina Osorto Contreras

Novo Nordisk, Søborg, Denmark

M

Melanie J. Davies

E

Eva Winning Lehmann

Novo Nordisk, Søborg, Denmark

K

Kirsi H. Pietilainen

Healthy Weight Hub, Helsinki University Central Hospital

D

Domenica Rubino

Washington Center for Weight Management and Research, Arlington, VA

P

Paolo Sbraccia

Department of Systems Medicine, University of Rome Tor Vergata, Internal Medicine Unit and Obesity Center, University Hospital Policlinico Tor Vergata, Rome

T

Thomas Wadden

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia

N

Niels Zeuthen

Novo Nordisk, Søborg, Denmark

J

John P.H. Wilding

Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom